Veterinary cardiac examination and diagnostic workup including murmur grading (I-VI), arrhythmia classification, echocardiography indications, and ACVIM staging for MMVD and DCM.
Veterinary cardiac examination and diagnostic workup including murmur grading (I-VI), arrhythmia classification, echocardiography indications, and ACVIM staging for MMVD and DCM.
| Grade | Description |
|---|---|
| I | Faint; heard only after prolonged auscultation in a quiet room |
| II | Soft but readily audible |
| III | Moderate intensity; no precordial thrill |
| IV | Loud; precordial thrill palpable |
| V |
| Very loud; thrill palpable; audible with stethoscope barely on chest |
| VI | Audible with stethoscope lifted off the chest wall; thrilling |
| Stage | Criteria |
|---|---|
| A | At risk (breed predisposition) but no structural disease |
| B1 | Murmur present; no cardiomegaly on imaging |
| B2 | Cardiomegaly confirmed: LA:Ao > 1.6 or LVIDDN ≥ 1.7 (radiographic and/or echocardiographic evidence of cardiomegaly). Treatment threshold. |
| C | Current or prior clinical signs of heart failure |
| D | Refractory heart failure despite standard therapy |
| Stage | Action |
|---|---|
| B1 | Monitor; no treatment indicated. Recheck echocardiogram q6-12 months. |
| B2 | Initiate pimobendan (0.25-0.3 mg/kg PO q12h). EPIC trial demonstrated 15-month median delay to onset of CHF. |
| C (first episode) | Pimobendan + furosemide (2-4 mg/kg PO q12h, titrate to effect) + ACE inhibitor (enalapril/benazepril 0.5 mg/kg q12h). |
| C (chronic) | Optimize furosemide dose; add spironolactone (1-2 mg/kg q12h). Consider dietary sodium restriction. |
| D (refractory) | Maximize diuretics (add hydrochlorothiazide 1-2 mg/kg q12h cautiously), sildenafil if pulmonary hypertension, consider pimobendan dose increase. Specialist referral strongly recommended. |
Canine:
Feline:
Equine: